Home › NDC Lookup › RxCUI directory › RxCUI 2744316

Acetaminophen 33.3 MG/ML / dextromethorphan hydrobromide 1 MG/ML / doxylamine succinate 0.... — RxCUI 2744316

Name: Acetaminophen 33.3 MG/ML / dextromethorphan hydrobromide 1 MG/ML / doxylamine succina… (RxCUI 2744316)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2744316 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2744316

Official nameAcetaminophen 33.3 MG/ML / dextromethorphan hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML Oral Suspension

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asAPAP 33.3 MG/ML / dextromethorphan hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML Oral Suspension; acetaminophen 1000 MG / dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 30 mL Oral Suspension

FDA products mapped1

Package NDCs mapped1

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Acetaminophen Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Great question. The IV form is used when you can't take medication by mouth — for example, after surgery, if you're nauseated, or if you need faster, more reliable absorption. It d...
Why am I getting acetaminophen through an IV instead of just taking a pill?
Yes, Acetaminophen Injection is approved for children — for pain relief in kids 2 years and older, and for fever reduction in patients of all ages, including premature newborns bor...
The most important things to watch for are signs of a serious allergic reaction — swelling of your face, mouth, or throat, trouble breathing, or hives — and any new skin rash. Eith...

📖 Read our full Acetaminophen Injection guide →

🕸️ Concept Web — How Acetaminophen 33.3 MG/ML / dextromethorphan hydr... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Acetaminophen 33.3 MG/ML / dextromethorphan hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML Oral Suspension RxCUI 2744316 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 6

The active substance itself — no strength, form, or brand attached yet.
- Acetaminophen 161 IN
- Dextromethorphan 3289 IN
- Doxylamine 3642 IN
- Acetaminophen / dextromethorphan / doxylamine 705258 MIN
- Dextromethorphan hydrobromide 102490 PIN
- Doxylamine succinate 23665 PIN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Acetaminophen / dextromethorphan / doxylamine Oral Suspension 2692300 SCDF
- Acetaminophen / dextromethorphan hydrobromide / doxylamine succinate Oral Suspension 2692301 SCDFP
- Acetaminophen / dextromethorphan / doxylamine Oral Liquid Product 1155901 SCDG
- Acetaminophen / dextromethorphan / doxylamine Oral Product 1155902 SCDG
- Acetaminophen / dextromethorphan hydrobromide / doxylamine succinate Oral Liquid Product 2660514 SCDGP
- Acetaminophen / dextromethorphan hydrobromide / doxylamine succinate Oral Product 2662124 SCDGP
- Oral Suspension 316969 DF
- Oral Liquid Product 1151137 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Acetaminophen 33.3 MG/ML 328877 SCDC
- Dextromethorphan hydrobromide 1 MG/ML 1020137 SCDC
- Doxylamine succinate 0.417 MG/ML 1042674 SCDC

Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Acetaminophen 33.3 MG/ML SCDC · 328877
Dextromethorphan hydrobromide 1 MG/ML SCDC · 1020137
Doxylamine succinate 0.417 MG/ML SCDC · 1042674
Acetaminophen / dextromethorphan / doxylamine Oral Suspension SCDF · 2692300
Acetaminophen / dextromethorphan hydrobromide / doxylamine succinate Oral Suspension SCDFP · 2692301
Acetaminophen / dextromethorphan / doxylamine Oral Liquid Product SCDG · 1155901
Acetaminophen / dextromethorphan / doxylamine Oral Product SCDG · 1155902
Acetaminophen / dextromethorphan hydrobromide / doxylamine succinate Oral Liquid Product SCDGP · 2660514
Acetaminophen / dextromethorphan hydrobromide / doxylamine succinate Oral Product SCDGP · 2662124

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 2744316 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
50580-0212-01	240 mL in 1 BOTTLE (50580-212-01)	Extra Strength Tylenol Cold plus Flu Multi-Symptom Nighttime	Kenvue Brands LLC	2026-06-01

Observed labelers: Kenvue Brands LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.